chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19, FLUX, RSV
Symptoms: Injection site pain, Loss of personal independence in daily activities, Pain in extremity, X-ray
Clinical narrative: muscle at the injection site is sore; He cannot lift anything more than 5 pounds.; Arm  soreness; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site muscle pain in a adult male patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   Co-suspect products included Influenza vaccine for prophylaxis and Tozinameran (Pfizer BioNTech COVID-19 vaccine) for prophylaxis.   On an unknown date, the patient received Arexvy (right arm), Influenza vaccine (left arm) and Pfizer BioNTech COVID-19 vaccine (left arm). On an unknown date, an unknown time after receiving Arexvy, the patient experienced injection site muscle pain (Verbatim: muscle at the injection site is sore), activities of daily living impaired (Verbatim: He cannot lift anything more than 5 pounds.) and pain in arm (Verbatim: Arm  soreness). The outcome of the injection site muscle pain and activities of daily living impaired were not reported and the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the injection site muscle pain, activities of daily living impaired and pain in arm to be related to Arexvy.     It was unknown if the company considered the injection site muscle pain, activities of daily living impaired and pain in arm to be related to Arexvy.   Additional Information: GSK receipt date: 22-DEC-2023 Reporter was the patient. The patient was received a dose of AREXVY 4 months ago on his right arm  and received a COVID-19 vaccine (Pfizer) and Flu vaccine (unknown manufacturer) on his left arm in the same visit.  The patient states that the muscle at the injection site was sore.  The patient cannot lift anything more than 5 pounds.  The patient was an X ray done on his rotator cuff to see if it was the cause for soreness.  The patient did not disclose results of exam. The reporter consented to follow up.
Age: 11.0
Sex: M
Vaccine: DTAP
Symptoms: Extra dose administered, Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: completed 5-series of Infanrix and was back for Boostrix booster; Infanrix was administered to a 11 y/o instead of Boostrix; Infanrix was administered to a 11 y/o; This non-serious case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 11-year-old male patient who received DTPa (Infanrix) (batch number 5H773, expiry date 13-JUL-2025) for prophylaxis.   Previously administered products included Infanrix (received 1st dose on an unknown date), Infanrix (received 2nd dose on an unknown date), Infanrix (received 3rd dose on an unknown date), Infanrix (received 4th dose on an unknown date) and Infanrix (received 5th dose on an unknown date).   On 18-DEC-2023, the patient received the 6th dose of Infanrix. On 18-DEC-2023, an unknown time after receiving Infanrix, the patient experienced extra dose administered (Verbatim: completed 5-series of Infanrix and was back for Boostrix booster), wrong vaccine administered (Verbatim: Infanrix was administered to a 11 y/o instead of Boostrix) and inappropriate age at vaccine administration (Verbatim: Infanrix was administered to a 11 y/o). The outcome of the extra dose administered, wrong vaccine administered and inappropriate age at vaccine administration were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 22-DEC-2023 The licensed practical nurse reported that the Infanrix vaccine was administered to a 11-year-old child instead of Boostrix, which led to wrong vaccine administered, extra dose administered and inappropriate age at vaccine administration. The patient had completed 5 series of Infanrix vaccine and was back for Boostrix booster. The reporter wanted to know could the Infanrix count as a completed series for the Boostrix. The reporter consented the follow up.up.
Age: 75.0
Sex: F
Vaccine: FLU4
Symptoms: Extra dose administered
Clinical narrative: patient received 3rd dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 75-year-old female patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent 2023-2024 season) (batch number 23G34, expiry date 27-JUN-2024) for prophylaxis.   Concomitant products included INFLUENZA VACCINE INACT SPLIT 4V (FLULAVAL QUADRIVALENT) and INFLUENZA VACCINE (INFLUENZA).   On 26-DEC-2023, the patient received the 3rd dose of FluLaval Quadrivalent 2023-2024 season. On 26-DEC-2023, an unknown time after receiving FluLaval Quadrivalent 2023-2024 season and not applicable after receiving FLULAVAL QUADRIVALENT, the patient experienced extra dose administered (Verbatim: patient received 3rd dose). The outcome of the extra dose administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 26-DEC-2023 The reporter inquired about FluLaval and what information was available about the administration of extra doses of FluLaval, which led to extra dose administration. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up granted.
Sex: U
Vaccine: TDAP
Symptoms: Product storage error
Clinical narrative: The highest temperature reported in temperature excursion was 50°F; This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in an unknown number of patients who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   On an unknown date, the unspecified number of patients received Boostrix. On an unknown date, an unknown time after receiving Boostrix, the patients experienced incorrect storage of drug (Verbatim: The highest temperature reported in temperature excursion was 50°F). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date:26-DEC-2023 The Nurse was called on 26th December 2023, to report on 8th September 2023 Boostrix vaccine was involved in a temperature excursion and was administered to an unknown number of patients. The reporter did not consent to follow up.
Age: 70.0
Sex: F
Vaccine: RSV
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient had 2nd dose of arexvy; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 70-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 2X7NA, expiry date 23-MAR-2025) and (batch number PK74B, expiry date 22-FEB-2025) for prophylaxis.   Concomitant products included RSV VACCINE PROT. SUBUNIT PREF3 (AREXVY).   On 26-DEC-2023, the patient received the 2nd dose of Arexvy. On 26-DEC-2023, an unknown time after receiving Arexvy and an unknown time after receiving AREXVY, the patient experienced extra dose administered (Verbatim: Patient had 2nd dose of arexvy). The outcome of the extra dose administered was unknown.   Additional Information: GSK Receipt Date: 27-DEC-2023 Pharmacist requested guidance on how to proceed or what to expect with a patient who was administered Arexvy vaccine on 2nd December 2023 and a 2nd dose on 26th December 2023, which led to extra dose administered. The patient had not reported any side effects at the time of the call. The reporter consented to follow up.
Sex: M
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination
Clinical narrative: second dose has not yet been given; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in March 2022).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: second dose has not yet been given). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 28-DEC-2023 The pharmacist stated that a second dose of Shingrix had not yet been given to the patient.  The reporter opted out of providing more information.  Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter did not consent to follow up.
Sex: F
Vaccine: MENB
Symptoms: Wrong product administered
Clinical narrative: patient inadvertently received a dose of Bexsero instead of Menactra; This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 16-year-old female patient who received Men B NVS (Bexsero) (batch number EN939, expiry date 31-OCT-2024) for prophylaxis.   Previously administered products included Menactra (1st dose received on 08-AUG-2020).   In DEC-2023, the patient received Bexsero. In DEC-2023, an unknown time after receiving Bexsero, the patient experienced wrong vaccine administered (Verbatim: patient inadvertently received a dose of Bexsero instead of Menactra). The outcome of the wrong vaccine administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 28-DEC-2023 The medical assistant stated that a patient inadvertently received a dose of Bexsero instead of Menactra this week (from the reporting date), which led to wrong vaccine administered. The reporter consented to follow up.
Age: 17.0
Sex: F
Vaccine: TDAP
Symptoms: Incorrect route of product administration, No adverse event
Clinical narrative: report that they have a patient that was administered with adacel intravenously with no reported adverse event; Initial information received on 15-Dec-2023 regarding an unsolicited valid non-serious case received from other health professional.  This case involves a 17 years old female patient who was administered with Diphtheria-2/Tetanus/5 AC Pertussis vaccine [Adacel] intravenously with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included cefradine (Ancef [cefradine]).  On 14-Dec-2023, the patient received 0.5 ml dose (frequency: once; strength: standard) of suspect Diphtheria-2/Tetanus/5 AC Pertussis vaccine Suspension for injection of lot 2CA69C1 and Expiry: 20-Jul-2025 via IV NOS route in unknown administration site for immunization; with no reported adverse event (incorrect route of product administration) (latency: same day).   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: HIBV
Symptoms: No adverse event, Product preparation issue
Clinical narrative: one of those children received the diluent only rather than the actual vaccine with no reported adverse event; Initial information received on 19-Dec-2023 regarding an unsolicited valid non-serious case received via other health professional.  This case involves Child and unknown gender patient and the reporter stated one of those children received the diluent only rather than the actual vaccine with no reported adverse event after receiving HIB (PRP/T) VACCINE [ACT-HIB].  The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided.  On an unknown date, the patient received an unknown dose of suspect HIB (PRP/T) VACCINE, Powder and solvent for solution for injection (strength, lot number, expiry date: unknown) via unknown route in unknown administration site for immunization and one of those children received the diluent only rather than the actual vaccine with no reported adverse event (product preparation error) (latency: same day).  Action Taken: Not applicable    Outcome: Unknown  Information on batch number was requested  Reportedly, HCP reported that 4 ACTHIB vaccines were given. One of the children received diluent only. Therefore one child received no vaccine at all. Since they do not know which child received no vaccine, all 4 will be revaccinated so extra dose   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: FLU4
Symptoms: Needle issue, No adverse event, Wrong technique in product usage process
Clinical narrative: report that they administered fluzone qiv np intramuscular route (90 degree angle) as per pi but the thing is the needle that was used is for subcutaneous administration size with no ae; Initial information received on 26-Dec-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves an unknown age and unknown gender patient who experienced report that they administered influenza quadrival a-b vaccine [fluzone qiv] intramuscular route (90 degree angle) as per pi but the thing is the needle that was used is for subcutaneous administration size with no adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a 0.5 ml dose of suspect influenza quadrival a-b vaccine Suspension for injection (lot UT8091A, expiry date: 30-Jun-2024 with unknown strength) via intramuscular route in unknown administration site as Immunization (90 degree angle) as per pi but the thing is the needle that was used is for subcutaneous administration size with no adverse event (wrong technique in product usage process) (latency: same day).  It was reported "They are asking what adverse effects to look out for and if the patient needs to be revaccinated."   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram, Angiogram cerebral, Aphasia, Blood glucose, CSF cell count
Clinical narrative: Micro-seizures starting approximately 2 weeks after 2nd dose given on 4/23/21. Seizures become more consistent resulting in a visit with primary care doctor and neurologist. An overnight stay was recommended on 06/23/21. Symptoms consisted of arrest in speech, eye rolling, arm stiffness. Micro-seizures happened about 5 times per hour and lasted for 5-8 seconds each time. Full seizure happened on 7/13/21, resulting in 4-day stay in the ICU. Pt. now takes 2 anti-seizure medications per day and 2 Rituximab infusions every 6 months (in-home). Lumbar puncture during ICU stay diagnosed him with the auto-immune disease called LGI1 Encephalitis.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: CSF culture, CSF white blood cell differential, Chest X-ray, Computerised tomogram head, Differential white blood cell count
Clinical narrative: Micro-seizures starting approximately 2 weeks after 2nd dose given on 4/23/21. Seizures become more consistent resulting in a visit with primary care doctor and neurologist. An overnight stay was recommended on 06/23/21. Symptoms consisted of arrest in speech, eye rolling, arm stiffness. Micro-seizures happened about 5 times per hour and lasted for 5-8 seconds each time. Full seizure happened on 7/13/21, resulting in 4-day stay in the ICU. Pt. now takes 2 anti-seizure medications per day and 2 Rituximab infusions every 6 months (in-home). Lumbar puncture during ICU stay diagnosed him with the auto-immune disease called LGI1 Encephalitis.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Drug screen, Electroencephalogram, Encephalitis autoimmune, Full blood count, Gaze palsy
Clinical narrative: Micro-seizures starting approximately 2 weeks after 2nd dose given on 4/23/21. Seizures become more consistent resulting in a visit with primary care doctor and neurologist. An overnight stay was recommended on 06/23/21. Symptoms consisted of arrest in speech, eye rolling, arm stiffness. Micro-seizures happened about 5 times per hour and lasted for 5-8 seconds each time. Full seizure happened on 7/13/21, resulting in 4-day stay in the ICU. Pt. now takes 2 anti-seizure medications per day and 2 Rituximab infusions every 6 months (in-home). Lumbar puncture during ICU stay diagnosed him with the auto-immune disease called LGI1 Encephalitis.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes simplex test, Intensive care, Laboratory test, Liver function test, Lumbar puncture abnormal
Clinical narrative: Micro-seizures starting approximately 2 weeks after 2nd dose given on 4/23/21. Seizures become more consistent resulting in a visit with primary care doctor and neurologist. An overnight stay was recommended on 06/23/21. Symptoms consisted of arrest in speech, eye rolling, arm stiffness. Micro-seizures happened about 5 times per hour and lasted for 5-8 seconds each time. Full seizure happened on 7/13/21, resulting in 4-day stay in the ICU. Pt. now takes 2 anti-seizure medications per day and 2 Rituximab infusions every 6 months (in-home). Lumbar puncture during ICU stay diagnosed him with the auto-immune disease called LGI1 Encephalitis.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Magnetic resonance imaging, Magnetic resonance imaging head, Metabolic function test, Musculoskeletal stiffness, Polymerase chain reaction
Clinical narrative: Micro-seizures starting approximately 2 weeks after 2nd dose given on 4/23/21. Seizures become more consistent resulting in a visit with primary care doctor and neurologist. An overnight stay was recommended on 06/23/21. Symptoms consisted of arrest in speech, eye rolling, arm stiffness. Micro-seizures happened about 5 times per hour and lasted for 5-8 seconds each time. Full seizure happened on 7/13/21, resulting in 4-day stay in the ICU. Pt. now takes 2 anti-seizure medications per day and 2 Rituximab infusions every 6 months (in-home). Lumbar puncture during ICU stay diagnosed him with the auto-immune disease called LGI1 Encephalitis.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Scan with contrast, Seizure, Staphylococcus test
Clinical narrative: Micro-seizures starting approximately 2 weeks after 2nd dose given on 4/23/21. Seizures become more consistent resulting in a visit with primary care doctor and neurologist. An overnight stay was recommended on 06/23/21. Symptoms consisted of arrest in speech, eye rolling, arm stiffness. Micro-seizures happened about 5 times per hour and lasted for 5-8 seconds each time. Full seizure happened on 7/13/21, resulting in 4-day stay in the ICU. Pt. now takes 2 anti-seizure medications per day and 2 Rituximab infusions every 6 months (in-home). Lumbar puncture during ICU stay diagnosed him with the auto-immune disease called LGI1 Encephalitis.
Age: 29.0
Sex: F
Vaccine: RSV
Symptoms: Arthralgia, Exposure during pregnancy, Injection site erythema, Injection site induration, Myalgia
Clinical narrative: 33w5d, due date 2/10/24 estimated birth weight 5 lbs. adverse event: severe muscle and joint aches (similar to aches usually associated with fever), redness and hardness at injection site. Painful and tender to the touch. Redness expanded on 12/30 and continued on 12/31 and 1/1
Age: 29.0
Sex: F
Vaccine: RSV
Symptoms: Pain, Product use issue, Tenderness
Clinical narrative: 33w5d, due date 2/10/24 estimated birth weight 5 lbs. adverse event: severe muscle and joint aches (similar to aches usually associated with fever), redness and hardness at injection site. Painful and tender to the touch. Redness expanded on 12/30 and continued on 12/31 and 1/1
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Alpha haemolytic streptococcal infection, Blood culture positive, Chills, Computerised tomogram thorax abnormal, Endocarditis
Clinical narrative: On September 14, 2023, I was admitted to Hospital with what turned out to be Endocarditis.  The bacteria found from blood cultures was strep mitis.  I was in the hospital for one week and continued with 5 and 1/2 weeks of iv penicillin G.  When the course of antibiotics completed fever and chills came back.  At that time, 10/31/2023, I went to another Hospital and was admitted.  I was given more antibiotics and found that a spot on my lung had doubled in size.  It is believed that the spot was infection but we never determined the exact bacteria.  I was discharged on 11/8/2023 with a weeks worth of amoxicillin-clavulanate.  A follow up ct scan of lungs on 12/24/2023 showed the lung spot had resolved.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pneumonia, Pyrexia
Clinical narrative: On September 14, 2023, I was admitted to Hospital with what turned out to be Endocarditis.  The bacteria found from blood cultures was strep mitis.  I was in the hospital for one week and continued with 5 and 1/2 weeks of iv penicillin G.  When the course of antibiotics completed fever and chills came back.  At that time, 10/31/2023, I went to another Hospital and was admitted.  I was given more antibiotics and found that a spot on my lung had doubled in size.  It is believed that the spot was infection but we never determined the exact bacteria.  I was discharged on 11/8/2023 with a weeks worth of amoxicillin-clavulanate.  A follow up ct scan of lungs on 12/24/2023 showed the lung spot had resolved.
Age: 60.0
Sex: F
Vaccine: DF
Symptoms: Pyrexia
Clinical narrative: Fever ranging from 99.5 to 100.8 over a 12 hour period.
Age: 67.0
Sex: F
Vaccine: RSV
Symptoms: Cellulitis, Injection site erythema
Clinical narrative: Redness at the injection site. Starting  day after injection and getting larger on day 4.  She had dr visit via phone and was prescribed antibiotics for cellulitus
Age: 72.0
Sex: F
Vaccine: RSV
Symptoms: Hyperhidrosis, Injection site reaction, Muscle tightness, Rash erythematous
Clinical narrative: Patient had muscle tension in legs, profuse sweating and red rash around inject site that was the size of an adult hand.
Age: 62.0
Sex: M
Vaccine: COVID19-2, RSV
Symptoms: Chills, Decreased appetite, Diarrhoea, Fatigue, Night sweats
Clinical narrative: 0300 12/30/23 Fever 102 degrees by oral thermometer, aches and pains, fatigue, chills, night sweats, diarrhea, loss of appetite.    Fever broke 0900 12/31/23 fatigue, diarhea, loss of appetite continued for another 36 hours
Age: 62.0
Sex: M
Vaccine: COVID19-2, RSV
Symptoms: Pain, Pyrexia
Clinical narrative: 0300 12/30/23 Fever 102 degrees by oral thermometer, aches and pains, fatigue, chills, night sweats, diarrhea, loss of appetite.    Fever broke 0900 12/31/23 fatigue, diarhea, loss of appetite continued for another 36 hours
Age: 67.0
Sex: F
Vaccine: RSV
Symptoms: Fatigue, Headache, Nausea
Clinical narrative: Incapacitating fatigue continuing for 14 days. Headache, nausea
Age: 19.0
Sex: M
Vaccine: MENB
Symptoms: Headache, Injection site inflammation, Pain in extremity
Clinical narrative: Persistent headache; extreme soreness in arm for several days; inflammation around injection site, which grew larger each day, and eventually reached from the shoulder to the bend in the arm; symptoms cleared after a week
Age: 68.0
Sex: F
Vaccine: RSV
Symptoms: Axillary pain, Injection site erythema, Injection site mass, Pain in extremity, Rash
Clinical narrative: Left arm redness and lump near site of injection,  red /rash under left armpit , aches in both calves-  Under arm and legs are still painful on day 3  Note, if pain persists, will  need to seek medical attention
Age: 68.0
Sex: F
Vaccine: RSV
Symptoms: Rash erythematous
Clinical narrative: Left arm redness and lump near site of injection,  red /rash under left armpit , aches in both calves-  Under arm and legs are still painful on day 3  Note, if pain persists, will  need to seek medical attention
Age: 83.0
Sex: F
Vaccine: COVID19-2, RSV
Symptoms: Arthralgia
Clinical narrative: patient's husband reported symptoms of prolonged shoulder pain.  patient was seen by provider (PCP) and urgent care with no resolution from providers.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Patient started experiencing hives and was prescribed prednisone 10mg by her Doctor
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Limb mass
Clinical narrative: Have developed lumps on my thighs and wrist and arm
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Bradyphrenia, Brain fog
Clinical narrative: Lot number unclear on receipt.  Here is all info:  Spikevax 2023-24 Vial 50 mcg/0.5 ml inj.  Covid-19 (Sars-Cov-2)Mrna VA. Reaction was that my brain was in a fog for the next week.  Thinking was slowed, and took more effort than usual.  This is distinctly different from my reaction to prior shots (4 of them), which were generally flu symptoms for about 24hrs.  This was the first time my brain was affected.  After about a week I perceived going back to normal, but I do not know if there are any lasting effects since it's hard to compare exactly.
Age: 74.0
Sex: F
Vaccine: RSV
Symptoms: Cold sweat, Fall, Feeling hot, Pallor, Syncope
Clinical narrative: fainted, fell and hit door,  couldn't remember passing out, just clammy and hot and pale, paramedics came and checked her out and she left here on her own doing ok
Age: 0.92
Sex: F
Vaccine: DTAPHEPBIP
Symptoms: Crying, Irritability, Pyrexia, Rash
Clinical narrative: Fever 103-104;  irritability, inconsolable;  rash
Age: 76.0
Sex: M
Vaccine: RSV
Symptoms: Pain in extremity
Clinical narrative: patient complained of extreme pain on left arm.  he went to the ER to get oxycodone for the pain.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Alanine aminotransferase increased, Arthralgia, Aspartate aminotransferase increased, Bladder catheterisation
Clinical narrative: Patient is a 51 y.o. male patient of No, Physician with history of chronic respiratory failure s/p trach placement 8/17/2023, GERD, HTN  presented on 11/13/2023 with shortness of breath and fevers.  He was diagnosed with COVID.  HMS consulted by MD for transfer to intermediate.    He is discharged home in stable and improved condition on room air with supplies for tracheostomy care and referrals for ENT and urology.  Patient updated on discharge plan and agrees.   Acute on chronic respiratory failure?resolved Tracheostomy in place Status post trach placement 8/17/2023. Has a 5 Shiley extra long proximal cuffless On room air Patient not complaining of respiratory distress. Patient and his roommate educated on tracheostomy care Will need ENT follow up on discharge, referral sent   Sepsis, on admission - resolved COVID 19 Pneumonia Hx of multiple mdr infections Aspiration pneumonitis/pneumonia Initial ED vitals showed mild tachycardia, afebrile, hypotensive. VSS, AF Improved VS, on TM not in any distress, feeling much better. Blood cultures,Urine antigens, MRSA probe neg.Initial lactic acid 0.8 COVID swab positive, isolation precautions started Given recent hospitalization with history of multidrug-resistant organisms, ID started on broad spectrum antibiotics. Procalcitonin negative, sputum culture NGTD, resp PCR NGTD Stop emperic abx. Completed Remdesivir dosing On Decadron 6mg daily x10 days for COVID-19 Noted elevated AST/ALT, may be related to remdesivir, appears to have plateaued and are now downtrending Remove COVID precautions 11/24   Urinary incontinence, reported States started after stay in select and long-term Foley Postvoid negative for urinary retention, unlikely overflow incontinence Trial oxybutynin Outpatient referral for urology   Dysphagia Food noted in patient's trach tubing Speech recommends nectar thick liquids with puréed solids Continued SLP on discharge Patient educated again on diet   Hypomagnesemia Replacement ordered   HFpEF, without exacerbation Elevated Troponin BNP at 863, similar and reduced from prior Delta troponin flat, around patients baseline Echo 9/25/23: EF 60-65% Patient asymptomatic; no NTSEMI PEG tube Placed during prior hospitalization with tracheostomy Has not used PEG tube since discharge from nursing facility Tolerates p.o. intake Consulted general surgery for PEG tube removal.  Patient did not want to have PEG tube removed after hearing about the process.  Can follow-up about this outpatient. Info in AVS   Left shoulder pain States has been told he has rotator cuff tear but c/o recent trauma prior to admission and now with left shoulder pain.  Xray shoulder: Chronic separation of the left acromioclavicular joint, OP f/u    Anxiety Continue home meds   GERD Continue home meds
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Blood culture negative, Blood lactic acid, Brain natriuretic peptide increased, COVID-19, COVID-19 pneumonia
Clinical narrative: Patient is a 51 y.o. male patient of No, Physician with history of chronic respiratory failure s/p trach placement 8/17/2023, GERD, HTN  presented on 11/13/2023 with shortness of breath and fevers.  He was diagnosed with COVID.  HMS consulted by MD for transfer to intermediate.    He is discharged home in stable and improved condition on room air with supplies for tracheostomy care and referrals for ENT and urology.  Patient updated on discharge plan and agrees.   Acute on chronic respiratory failure?resolved Tracheostomy in place Status post trach placement 8/17/2023. Has a 5 Shiley extra long proximal cuffless On room air Patient not complaining of respiratory distress. Patient and his roommate educated on tracheostomy care Will need ENT follow up on discharge, referral sent   Sepsis, on admission - resolved COVID 19 Pneumonia Hx of multiple mdr infections Aspiration pneumonitis/pneumonia Initial ED vitals showed mild tachycardia, afebrile, hypotensive. VSS, AF Improved VS, on TM not in any distress, feeling much better. Blood cultures,Urine antigens, MRSA probe neg.Initial lactic acid 0.8 COVID swab positive, isolation precautions started Given recent hospitalization with history of multidrug-resistant organisms, ID started on broad spectrum antibiotics. Procalcitonin negative, sputum culture NGTD, resp PCR NGTD Stop emperic abx. Completed Remdesivir dosing On Decadron 6mg daily x10 days for COVID-19 Noted elevated AST/ALT, may be related to remdesivir, appears to have plateaued and are now downtrending Remove COVID precautions 11/24   Urinary incontinence, reported States started after stay in select and long-term Foley Postvoid negative for urinary retention, unlikely overflow incontinence Trial oxybutynin Outpatient referral for urology   Dysphagia Food noted in patient's trach tubing Speech recommends nectar thick liquids with puréed solids Continued SLP on discharge Patient educated again on diet   Hypomagnesemia Replacement ordered   HFpEF, without exacerbation Elevated Troponin BNP at 863, similar and reduced from prior Delta troponin flat, around patients baseline Echo 9/25/23: EF 60-65% Patient asymptomatic; no NTSEMI PEG tube Placed during prior hospitalization with tracheostomy Has not used PEG tube since discharge from nursing facility Tolerates p.o. intake Consulted general surgery for PEG tube removal.  Patient did not want to have PEG tube removed after hearing about the process.  Can follow-up about this outpatient. Info in AVS   Left shoulder pain States has been told he has rotator cuff tear but c/o recent trauma prior to admission and now with left shoulder pain.  Xray shoulder: Chronic separation of the left acromioclavicular joint, OP f/u    Anxiety Continue home meds   GERD Continue home meds
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Dysphagia, Dyspnoea, Echocardiogram, Ejection fraction normal, Gastrostomy
Clinical narrative: Patient is a 51 y.o. male patient of No, Physician with history of chronic respiratory failure s/p trach placement 8/17/2023, GERD, HTN  presented on 11/13/2023 with shortness of breath and fevers.  He was diagnosed with COVID.  HMS consulted by MD for transfer to intermediate.    He is discharged home in stable and improved condition on room air with supplies for tracheostomy care and referrals for ENT and urology.  Patient updated on discharge plan and agrees.   Acute on chronic respiratory failure?resolved Tracheostomy in place Status post trach placement 8/17/2023. Has a 5 Shiley extra long proximal cuffless On room air Patient not complaining of respiratory distress. Patient and his roommate educated on tracheostomy care Will need ENT follow up on discharge, referral sent   Sepsis, on admission - resolved COVID 19 Pneumonia Hx of multiple mdr infections Aspiration pneumonitis/pneumonia Initial ED vitals showed mild tachycardia, afebrile, hypotensive. VSS, AF Improved VS, on TM not in any distress, feeling much better. Blood cultures,Urine antigens, MRSA probe neg.Initial lactic acid 0.8 COVID swab positive, isolation precautions started Given recent hospitalization with history of multidrug-resistant organisms, ID started on broad spectrum antibiotics. Procalcitonin negative, sputum culture NGTD, resp PCR NGTD Stop emperic abx. Completed Remdesivir dosing On Decadron 6mg daily x10 days for COVID-19 Noted elevated AST/ALT, may be related to remdesivir, appears to have plateaued and are now downtrending Remove COVID precautions 11/24   Urinary incontinence, reported States started after stay in select and long-term Foley Postvoid negative for urinary retention, unlikely overflow incontinence Trial oxybutynin Outpatient referral for urology   Dysphagia Food noted in patient's trach tubing Speech recommends nectar thick liquids with puréed solids Continued SLP on discharge Patient educated again on diet   Hypomagnesemia Replacement ordered   HFpEF, without exacerbation Elevated Troponin BNP at 863, similar and reduced from prior Delta troponin flat, around patients baseline Echo 9/25/23: EF 60-65% Patient asymptomatic; no NTSEMI PEG tube Placed during prior hospitalization with tracheostomy Has not used PEG tube since discharge from nursing facility Tolerates p.o. intake Consulted general surgery for PEG tube removal.  Patient did not want to have PEG tube removed after hearing about the process.  Can follow-up about this outpatient. Info in AVS   Left shoulder pain States has been told he has rotator cuff tear but c/o recent trauma prior to admission and now with left shoulder pain.  Xray shoulder: Chronic separation of the left acromioclavicular joint, OP f/u    Anxiety Continue home meds   GERD Continue home meds
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Hypomagnesaemia, Hypotension, Injury, Joint dislocation, Left ventricular failure
Clinical narrative: Patient is a 51 y.o. male patient of No, Physician with history of chronic respiratory failure s/p trach placement 8/17/2023, GERD, HTN  presented on 11/13/2023 with shortness of breath and fevers.  He was diagnosed with COVID.  HMS consulted by MD for transfer to intermediate.    He is discharged home in stable and improved condition on room air with supplies for tracheostomy care and referrals for ENT and urology.  Patient updated on discharge plan and agrees.   Acute on chronic respiratory failure?resolved Tracheostomy in place Status post trach placement 8/17/2023. Has a 5 Shiley extra long proximal cuffless On room air Patient not complaining of respiratory distress. Patient and his roommate educated on tracheostomy care Will need ENT follow up on discharge, referral sent   Sepsis, on admission - resolved COVID 19 Pneumonia Hx of multiple mdr infections Aspiration pneumonitis/pneumonia Initial ED vitals showed mild tachycardia, afebrile, hypotensive. VSS, AF Improved VS, on TM not in any distress, feeling much better. Blood cultures,Urine antigens, MRSA probe neg.Initial lactic acid 0.8 COVID swab positive, isolation precautions started Given recent hospitalization with history of multidrug-resistant organisms, ID started on broad spectrum antibiotics. Procalcitonin negative, sputum culture NGTD, resp PCR NGTD Stop emperic abx. Completed Remdesivir dosing On Decadron 6mg daily x10 days for COVID-19 Noted elevated AST/ALT, may be related to remdesivir, appears to have plateaued and are now downtrending Remove COVID precautions 11/24   Urinary incontinence, reported States started after stay in select and long-term Foley Postvoid negative for urinary retention, unlikely overflow incontinence Trial oxybutynin Outpatient referral for urology   Dysphagia Food noted in patient's trach tubing Speech recommends nectar thick liquids with puréed solids Continued SLP on discharge Patient educated again on diet   Hypomagnesemia Replacement ordered   HFpEF, without exacerbation Elevated Troponin BNP at 863, similar and reduced from prior Delta troponin flat, around patients baseline Echo 9/25/23: EF 60-65% Patient asymptomatic; no NTSEMI PEG tube Placed during prior hospitalization with tracheostomy Has not used PEG tube since discharge from nursing facility Tolerates p.o. intake Consulted general surgery for PEG tube removal.  Patient did not want to have PEG tube removed after hearing about the process.  Can follow-up about this outpatient. Info in AVS   Left shoulder pain States has been told he has rotator cuff tear but c/o recent trauma prior to admission and now with left shoulder pain.  Xray shoulder: Chronic separation of the left acromioclavicular joint, OP f/u    Anxiety Continue home meds   GERD Continue home meds
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonitis aspiration, Polymerase chain reaction negative, Procalcitonin normal, Pyrexia, Rotator cuff syndrome
Clinical narrative: Patient is a 51 y.o. male patient of No, Physician with history of chronic respiratory failure s/p trach placement 8/17/2023, GERD, HTN  presented on 11/13/2023 with shortness of breath and fevers.  He was diagnosed with COVID.  HMS consulted by MD for transfer to intermediate.    He is discharged home in stable and improved condition on room air with supplies for tracheostomy care and referrals for ENT and urology.  Patient updated on discharge plan and agrees.   Acute on chronic respiratory failure?resolved Tracheostomy in place Status post trach placement 8/17/2023. Has a 5 Shiley extra long proximal cuffless On room air Patient not complaining of respiratory distress. Patient and his roommate educated on tracheostomy care Will need ENT follow up on discharge, referral sent   Sepsis, on admission - resolved COVID 19 Pneumonia Hx of multiple mdr infections Aspiration pneumonitis/pneumonia Initial ED vitals showed mild tachycardia, afebrile, hypotensive. VSS, AF Improved VS, on TM not in any distress, feeling much better. Blood cultures,Urine antigens, MRSA probe neg.Initial lactic acid 0.8 COVID swab positive, isolation precautions started Given recent hospitalization with history of multidrug-resistant organisms, ID started on broad spectrum antibiotics. Procalcitonin negative, sputum culture NGTD, resp PCR NGTD Stop emperic abx. Completed Remdesivir dosing On Decadron 6mg daily x10 days for COVID-19 Noted elevated AST/ALT, may be related to remdesivir, appears to have plateaued and are now downtrending Remove COVID precautions 11/24   Urinary incontinence, reported States started after stay in select and long-term Foley Postvoid negative for urinary retention, unlikely overflow incontinence Trial oxybutynin Outpatient referral for urology   Dysphagia Food noted in patient's trach tubing Speech recommends nectar thick liquids with puréed solids Continued SLP on discharge Patient educated again on diet   Hypomagnesemia Replacement ordered   HFpEF, without exacerbation Elevated Troponin BNP at 863, similar and reduced from prior Delta troponin flat, around patients baseline Echo 9/25/23: EF 60-65% Patient asymptomatic; no NTSEMI PEG tube Placed during prior hospitalization with tracheostomy Has not used PEG tube since discharge from nursing facility Tolerates p.o. intake Consulted general surgery for PEG tube removal.  Patient did not want to have PEG tube removed after hearing about the process.  Can follow-up about this outpatient. Info in AVS   Left shoulder pain States has been told he has rotator cuff tear but c/o recent trauma prior to admission and now with left shoulder pain.  Xray shoulder: Chronic separation of the left acromioclavicular joint, OP f/u    Anxiety Continue home meds   GERD Continue home meds
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sepsis, Sputum culture, Staphylococcus test negative, Tachycardia
Clinical narrative: Patient is a 51 y.o. male patient of No, Physician with history of chronic respiratory failure s/p trach placement 8/17/2023, GERD, HTN  presented on 11/13/2023 with shortness of breath and fevers.  He was diagnosed with COVID.  HMS consulted by MD for transfer to intermediate.    He is discharged home in stable and improved condition on room air with supplies for tracheostomy care and referrals for ENT and urology.  Patient updated on discharge plan and agrees.   Acute on chronic respiratory failure?resolved Tracheostomy in place Status post trach placement 8/17/2023. Has a 5 Shiley extra long proximal cuffless On room air Patient not complaining of respiratory distress. Patient and his roommate educated on tracheostomy care Will need ENT follow up on discharge, referral sent   Sepsis, on admission - resolved COVID 19 Pneumonia Hx of multiple mdr infections Aspiration pneumonitis/pneumonia Initial ED vitals showed mild tachycardia, afebrile, hypotensive. VSS, AF Improved VS, on TM not in any distress, feeling much better. Blood cultures,Urine antigens, MRSA probe neg.Initial lactic acid 0.8 COVID swab positive, isolation precautions started Given recent hospitalization with history of multidrug-resistant organisms, ID started on broad spectrum antibiotics. Procalcitonin negative, sputum culture NGTD, resp PCR NGTD Stop emperic abx. Completed Remdesivir dosing On Decadron 6mg daily x10 days for COVID-19 Noted elevated AST/ALT, may be related to remdesivir, appears to have plateaued and are now downtrending Remove COVID precautions 11/24   Urinary incontinence, reported States started after stay in select and long-term Foley Postvoid negative for urinary retention, unlikely overflow incontinence Trial oxybutynin Outpatient referral for urology   Dysphagia Food noted in patient's trach tubing Speech recommends nectar thick liquids with puréed solids Continued SLP on discharge Patient educated again on diet   Hypomagnesemia Replacement ordered   HFpEF, without exacerbation Elevated Troponin BNP at 863, similar and reduced from prior Delta troponin flat, around patients baseline Echo 9/25/23: EF 60-65% Patient asymptomatic; no NTSEMI PEG tube Placed during prior hospitalization with tracheostomy Has not used PEG tube since discharge from nursing facility Tolerates p.o. intake Consulted general surgery for PEG tube removal.  Patient did not want to have PEG tube removed after hearing about the process.  Can follow-up about this outpatient. Info in AVS   Left shoulder pain States has been told he has rotator cuff tear but c/o recent trauma prior to admission and now with left shoulder pain.  Xray shoulder: Chronic separation of the left acromioclavicular joint, OP f/u    Anxiety Continue home meds   GERD Continue home meds
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Tracheostomy, Troponin increased, Urinary incontinence, Urine antigen test, X-ray limb abnormal
Clinical narrative: Patient is a 51 y.o. male patient of No, Physician with history of chronic respiratory failure s/p trach placement 8/17/2023, GERD, HTN  presented on 11/13/2023 with shortness of breath and fevers.  He was diagnosed with COVID.  HMS consulted by MD for transfer to intermediate.    He is discharged home in stable and improved condition on room air with supplies for tracheostomy care and referrals for ENT and urology.  Patient updated on discharge plan and agrees.   Acute on chronic respiratory failure?resolved Tracheostomy in place Status post trach placement 8/17/2023. Has a 5 Shiley extra long proximal cuffless On room air Patient not complaining of respiratory distress. Patient and his roommate educated on tracheostomy care Will need ENT follow up on discharge, referral sent   Sepsis, on admission - resolved COVID 19 Pneumonia Hx of multiple mdr infections Aspiration pneumonitis/pneumonia Initial ED vitals showed mild tachycardia, afebrile, hypotensive. VSS, AF Improved VS, on TM not in any distress, feeling much better. Blood cultures,Urine antigens, MRSA probe neg.Initial lactic acid 0.8 COVID swab positive, isolation precautions started Given recent hospitalization with history of multidrug-resistant organisms, ID started on broad spectrum antibiotics. Procalcitonin negative, sputum culture NGTD, resp PCR NGTD Stop emperic abx. Completed Remdesivir dosing On Decadron 6mg daily x10 days for COVID-19 Noted elevated AST/ALT, may be related to remdesivir, appears to have plateaued and are now downtrending Remove COVID precautions 11/24   Urinary incontinence, reported States started after stay in select and long-term Foley Postvoid negative for urinary retention, unlikely overflow incontinence Trial oxybutynin Outpatient referral for urology   Dysphagia Food noted in patient's trach tubing Speech recommends nectar thick liquids with puréed solids Continued SLP on discharge Patient educated again on diet   Hypomagnesemia Replacement ordered   HFpEF, without exacerbation Elevated Troponin BNP at 863, similar and reduced from prior Delta troponin flat, around patients baseline Echo 9/25/23: EF 60-65% Patient asymptomatic; no NTSEMI PEG tube Placed during prior hospitalization with tracheostomy Has not used PEG tube since discharge from nursing facility Tolerates p.o. intake Consulted general surgery for PEG tube removal.  Patient did not want to have PEG tube removed after hearing about the process.  Can follow-up about this outpatient. Info in AVS   Left shoulder pain States has been told he has rotator cuff tear but c/o recent trauma prior to admission and now with left shoulder pain.  Xray shoulder: Chronic separation of the left acromioclavicular joint, OP f/u    Anxiety Continue home meds   GERD Continue home meds
Age: 66.0
Sex: M
Vaccine: RSV
Symptoms: Discomfort, Pain, Poor quality sleep
Clinical narrative: PATIENT SAYS HE HAS EXPERIENCE  PAIN AND DISCOMFORT SINCE VACCINATION.   HE HAS BEEN DOSING HIMSELF WITH OTC PAIN RELEIVERS.  HE DESCRIBES THE PAIN AS CONSTANT BUT EXCRUCIATING IN THE EVENING HOURS , PROHIBITING HIM FROM GETTING RESTFUL SLEEP
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Eye laser surgery, Retinal tear, Vitreous floaters
Clinical narrative: Woke up next morning with a lot of floaters in my right eye. Couldn?t get into see dr for 3 weeks, he said my retina was thin but okay. Saw another opthamalogist 6 weeks  later bc vision was impaired and he said I had a retinal tear in my eight eye and asked if I had any floaters recently and I said yes, at the end of May, the day after my covid vaccine. He said I?ve had this tear for a couple of months. That?s when I connected the dots between my vaccine and the retinal tear.  I had a detached retina in my left eye when u was 26 yo, so I am prone to retinal tears.